WIC
TEVA icon

Water Island Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Water Island Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-311,678
Closed -$18.4M – 116
2015
Q2 		$18.4M Buy
+311,678
New +$19.2M 0.74% 29

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Water Island Capital's TEVA Position: Q3 2015 in Review

Water Island Capital sold out of Teva Pharmaceuticals (TEVA) in Q3 2015, closing a stake of 311,678 shares — an estimated $18.4M sold.

Water Island Capital first reported a position in TEVA in Q2 2015 and held it in 1 quarter. The position peaked at $18.4M in Q2 2015. 823 funds tracked by Wall St. Rank hold TEVA as of Q3 2015.

  • Water Island Capital reported no remaining Teva Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • Water Island Capital sold 311,678 Teva Pharmaceuticals shares in Q3 2015, an estimated $18.4M.
  • Water Island Capital first reported a position in Teva Pharmaceuticals in Q2 2015 and held it in 1 quarter.
  • Water Island Capital's Teva Pharmaceuticals position peaked at $18.4M in Q2 2015.
  • 823 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2015.

Based on Water Island Capital's 13F filing for Q3 2015, filed 13 Nov 2015.